P/B
—
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
$64.7M
Market Cap • 10/2/2026
2010
(16 years)
Founded
2024
(2 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
—
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
64,7M
EV
78,3M
EV/Revenue
0
EV/EBITDA
-0,9
EV/EBIT
-0,9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-166,5%
Total Yield
-166,5%
Payout
0%
Retained Earnings
-572,6M
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
33,9%
% Goodwill
0%
ROE
1063%
ROIC
—
Growth
CAGR Op. Income 5Y
22,7%
CAGR Net Income 5Y
26,5%
CAGR EPS 5Y
-48,3%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
3,2
Quick Ratio
3
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!